UBS analyst Thyra Lee initiated coverage of Ambu (AMBFF) with a Buy rating and DKK 147 price target The company is set to deliver mid-teens sales and mid-20s earnings growth, driven by its leading ability to win in the shift from reusable to single-use endoscopes, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMBFF: